Shandong Second Provincial General Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Coronary artery disease2 trials
• Childhood cancers1 trial
• Diabetic eye disease1 trial
• Gastric and oesophageal cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 42 trials
• Phase 11 trial
• Phase 31 trial

Status

• Completed3 trials
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Beletalent (Zhuhai) Pharmaceutical Co., Ltd1 trial
• Chongqing Precision Biotech Co., Ltd1 trial
• Harbin Medical University1 trial
• Qilu Hospital of Shandong University1 trial
• The First Hospital of Jilin University1 trial

Running trials

• Recruiting

  Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

  NCT06817265· Phase 3· Beletalent (Zhuhai) Pharmaceutical Co., Ltd· Source

  Contact: Hong Wang

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease1 recruiting

Closed trials

• Completed

  Real-time AI-assisted Endocyroscopy for the Diagnosis of Colorectal Lesions

  NCT06791395· The First Hospital of Jilin University· Source

• Recruiting

  The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

  NCT04728516· Phase 4· Qilu Hospital of Shandong University· Source

  Contact: Yuan Bian, MD, PhD

• Completed

  Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

  NCT05415475· Phase 1· Chongqing Precision Biotech Co., Ltd· Source

• Completed

  Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

  NCT04624854· Phase 4· Harbin Medical University· Source